AdamIraSherwatMD
Infectious Disease • Washington, DCAssistant Professor, Medicine, Georgetown University School of Medicine
Are you Dr. Sherwat?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-687-6845
Summary
- Dr. Adam Sherwat, MD is an infectious disease specialist in Washington, District of Columbia. He is currently licensed to practice medicine in Maryland. He is an Assistant Professor at Georgetown University School of Medicine.
Education & Training
University of Cincinnati College of MedicineClass of 1996
Certifications & Licensure
MD State Medical License 2008 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 84 citationsTecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.Adam Sherwat, John T Brooks, Debra Birnkrant, Peter Kim
The New England Journal of Medicine. 2022-08-18 - 124 citationsFDA Approval of Remdesivir - A Step in the Right Direction.Daniel B. Rubin, Kirk M Chan-Tack, John Farley, Adam Sherwat
The New England Journal of Medicine. 2020-12-02 - 22 citationsAssessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.Kirk M Chan-Tack, Patrick R. Harrington, Su-Young Choi, Laine Myers, Julian J. O'Rear
The Lancet. Infectious Diseases. 2019-06-01
Press Mentions
Sept. 16, 2022: National Advocacy UpdateSeptember 16th, 2022- FDA Warns Monkeypox Could Mutate if Antiviral Drug Is OverusedSeptember 14th, 2022
- What Physicians Need to Know About Tecovirimat (TPOXX) for Treatment of MonkeypoxSeptember 13th, 2022
- Join now to see all
